189 related articles for article (PubMed ID: 24092361)
1. Ischemic heart diseases in Egypt: role of xanthine oxidase system and ischemia-modified albumin.
Ali OS; Abdelgawad HM; Mohammed MS; El-Awady RR
Heart Vessels; 2014 Sep; 29(5):629-37. PubMed ID: 24092361
[TBL] [Abstract][Full Text] [Related]
2. Role of ischemia-modified albumin in estimating the extent and scope of cardiac ischemia in patients with ST elevation myocardial infarction.
Chek J; Dusek J; Stasek J; Vojacek J; Bis J; Ulrychova M; Tichy M; Tomko T; Bukac J
Heart Vessels; 2011 Nov; 26(6):622-7. PubMed ID: 21267579
[TBL] [Abstract][Full Text] [Related]
3. [Diagnostic and prognostic value of atherosclerosis risk factors for predicting 1 year outcome in patients with acute myocardial infarction and in patients with stable coronary artery disease receiving percutaneous transluminal coronary angioplasty].
Drobniak-Hełdak D; Kolasińska-Kloch W; Rajtar-Salwa R
Folia Med Cracov; 2009; 50(3-4):43-54. PubMed ID: 21853870
[TBL] [Abstract][Full Text] [Related]
4. Serum level of Xanthine oxidase, Uric Acid, and NADPH oxidase1 in Stage I of Multiple Myeloma.
Kohsari M; Khadem Ansari MH; Rasmi Y
Asian Pac J Cancer Prev; 2020 Aug; 21(8):2237-2242. PubMed ID: 32856850
[TBL] [Abstract][Full Text] [Related]
5. [Application of Ischemia Modified Albumin for Acute Ischemic Heart Disease in Forensic Science].
Wang P; Zhu ZL; Zhu N; Yu H; Yue Q; Wang XL; Feng CM; Wang CL; Zhang GH
Fa Yi Xue Za Zhi; 2017 Oct; 33(5):493-496. PubMed ID: 29275553
[TBL] [Abstract][Full Text] [Related]
6. [N-terminal pro-brain natriuretic peptide (NT-proBNP) and ischemia modified albumin (IMA) in exercise induced ischemia in patients with stable coronary artery disease].
Piechota WN; Wierzbowski R; Piechota WT; Bejm J; Gielerak G
Pol Arch Med Wewn; 2006 Jul; 116(1):640-7. PubMed ID: 17340970
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of ischemia-modified albumin in myocardial infarction and prostatic diseases.
Mastella AK; Moresco RN; da Silva DB; Becker AM; Duarte MM; Giovelli LL; da Silva SH; Rossato L; Moretto MB; da Silva JE
Biomed Pharmacother; 2009 Dec; 63(10):762-6. PubMed ID: 19375269
[TBL] [Abstract][Full Text] [Related]
8. Ischemia-modified albumin is not better than creatine kinase-MB and cardiac troponin I in predicting a cardiac injury in nontraumatic subarachnoid hemorrhage.
Baydin A; Amanvermez R; Tuncel ÖK; Ocak M; Meric M; Cokluk C
Am J Emerg Med; 2015 Apr; 33(4):488-92. PubMed ID: 25744145
[TBL] [Abstract][Full Text] [Related]
9. Ischemic-Modified Albumin in Neonates with Congenital Heart Defects.
Korkut DG; Özlü F; Atlı G; Yıldız ŞM; Demir F; Göçen U; Yapıcıoğlu H
Am J Perinatol; 2024 May; 41(S 01):e827-e832. PubMed ID: 36584690
[TBL] [Abstract][Full Text] [Related]
10. A novel indicator of widespread endothelial damage and ischemia in diabetic patients: ischemia-modified albumin.
Ukinc K; Eminagaoglu S; Ersoz HO; Erem C; Karahan C; Hacihasanoglu AB; Kocak M
Endocrine; 2009 Dec; 36(3):425-32. PubMed ID: 19784800
[TBL] [Abstract][Full Text] [Related]
11. The relation between ischemia modified albumin levels and carotid intima media thickness in patients with rheumatoid arthritis.
Uslu AU; Kucuk A; Balta S; Ozturk C; Arslan S; Tekin L; Kucuksen S; Toker A; Kayrak M
Int J Rheum Dis; 2019 Jan; 22(1):32-37. PubMed ID: 27028097
[TBL] [Abstract][Full Text] [Related]
12. Ischemia-modified albumin in differential diagnosis of acute coronary syndrome without ST elevation and unstable angina pectoris.
Wudkowska A; Goch J; Goch A
Kardiol Pol; 2010 Apr; 68(4):431-7. PubMed ID: 20425705
[TBL] [Abstract][Full Text] [Related]
13. Serum and saliva levels of ischemia-modified albumin in patients with acute myocardial infarction.
Toker A; Aribas A; Yerlikaya FH; Tasyurek E; Akbuğa K
J Clin Lab Anal; 2013 Mar; 27(2):99-104. PubMed ID: 23400892
[TBL] [Abstract][Full Text] [Related]
14. Pentraxin 3, ischemia-modified albumin, and myeloperoxidase in predicting a cardiac damage in acute carbon monoxide poisoning.
Baydin A; Amanvermez R; Çelebi HE; Tunçel ÖK; Demircan S
Am J Emerg Med; 2016 Oct; 34(10):1927-1930. PubMed ID: 27567420
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of human serum albumin cobalt binding assay for the assessment of myocardial ischemia and myocardial infarction.
Bhagavan NV; Lai EM; Rios PA; Yang J; Ortega-Lopez AM; Shinoda H; Honda SA; Rios CN; Sugiyama CE; Ha CE
Clin Chem; 2003 Apr; 49(4):581-5. PubMed ID: 12651810
[TBL] [Abstract][Full Text] [Related]
16. Association between serum lipoprotein-associated phospholipase A2, ischemic modified albumin and acute coronary syndrome: a cross-sectional study.
Yang F; Ma L; Zhang L; Wang Y; Zhao C; Zhu W; Liang W; Liu Q
Heart Vessels; 2019 Oct; 34(10):1608-1614. PubMed ID: 30963302
[TBL] [Abstract][Full Text] [Related]
17. Serum ischemic modified albumin (IMA) concentration and IMA/albumin ratio in patients with hepatitis B-related chronic liver diseases.
Yavuz F; Biyik M; Asil M; Dertli R; Demir A; Polat H; Uysal S; Ataseven H
Turk J Med Sci; 2017 Jun; 47(3):947-953. PubMed ID: 28618749
[TBL] [Abstract][Full Text] [Related]
18. Oxidative stress and ischemia-modified albumin in chronic ischemic heart failure.
Ellidag HY; Eren E; Yılmaz N; Cekin Y
Redox Rep; 2014 May; 19(3):118-23. PubMed ID: 24620936
[TBL] [Abstract][Full Text] [Related]
19. Association between the plasma levels of IMA and coronary atherosclerotic plaque burden and ischemic burden in early phase of non-ST-segment-elevation acute coronary syndromes.
Turan T; Akyüz AR; Sahin S; Kul S; Yilmaz AS; Kara F; Mentese SO; Aykan AÇ; Demir S; Celik S; Karahan SC
Eur Rev Med Pharmacol Sci; 2017 Feb; 21(3):576-583. PubMed ID: 28239809
[TBL] [Abstract][Full Text] [Related]
20. Comparison of pentraxin-3 and ischemia-modified albumin with troponin in early diagnosis of acute coronary syndrome.
Demir MT; Baydin A; Amanvermez R; Erenler AK; Güzel M; Yücel O
Bratisl Lek Listy; 2018; 119(8):509-512. PubMed ID: 30160160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
